ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

In Radio Address, Clinton Outlines Administration Priorities

October 2, 1998

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

Case Western Wins Renewal.

October 5, 2001

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002